Tscan Therapeutics, Inc. · NASDAQ:TCRX
Adage Capital Management, L.P.'s stake in Tscan Therapeutics, Inc. fell to 2.52% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 12, 2025
Adage Capital Management, L.P.'s stake in Tscan Therapeutics, Inc. fell to 2.52%, 1,350,000 shares, as a passive investor on Jun 30, 2025. Filed Aug 12, 2025 (Schedule 13G/A).
- Stake
- 2.52%
- Shares
- 1,350,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 2.52% | 1,350,000 |
| Robert Atchinson | 2.52% | 1,350,000 |
| Phillip Gross | 2.52% | 1,350,000 |
Source
Related
- Tscan Therapeutics, Inc.
- Adage Capital Management, L.P.
- Tscan Therapeutics, Inc. shareholders
- Form 4 · MacBeath Gavin · Oct 2, 2026
- Form 4 · Zdraveski Zoran · Oct 2, 2026
- Schedule 13G · Readout Capital, LP · Sep 25, 2026
- Schedule 13G/A · Lynx1 Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Bvf Partners L P · Aug 14, 2026